Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aci-Jel 0.94% vaginal jelly
0702020B0BBAAAA
|
Aci-Jel | Acetic acid | Obstetrics, Gynaecology and Urinary-Tract Disorders | No data available |
|
Aciclovir 1g/40ml solution for infusion vials
0503021C0AAAKAK
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 250mg powder for solution for infusion vials
0503021B0AAAAAA
|
Aciclovir sodium | Aciclovir sodium | Infections | No data available |
|
Aciclovir 250mg/10ml solution for infusion vials
0503021C0AAAIAI
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Aciclovir 500mg powder for solution for infusion vials
0503021B0AAABAB
|
Aciclovir sodium | Aciclovir sodium | Infections | No data available |
|
Aciclovir 500mg/20ml solution for infusion vials
0503021C0AAAJAJ
|
Aciclovir (Systemic) | Aciclovir | Infections | No data available |
|
Acid-Eze 200mg tablets
0103010D0BLAAAA
|
Acid-Eze | Cimetidine | Gastro-Intestinal System | No data available |
|
Acidophilus 500mg capsules
091104000BBBWA0
|
Proprietary compound preparation BNF 0911040 | Other digestive aid preparations | Nutrition and Blood | No data available |
|
Acitak 400mg tablets
0103010D0BKAAAB
|
Acitak | Cimetidine | Gastro-Intestinal System | No data available |
|
Acitra 150mg tablets
0905013F0BKACAC
|
Acitra | Magnesium citrate | Nutrition and Blood | No data available |
|
Acitretin 10mg/5ml oral solution
1305020A0AAAFAF
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 10mg/5ml oral suspension
1305020A0AAADAD
|
Acitretin | Acitretin | Skin | No data available |
|
Acitretin 5mg/5ml oral solution
1305020A0AAACAC
|
Acitretin | Acitretin | Skin | No data available |
|
Aclasta 5mg/100ml solution for infusion bottles
0606020V0BCAAAC
|
Aclasta | Zoledronic acid | Endocrine System | No data available |
|
Acnamino MR 100mg capsules (Almus)
0501030P0BHABAC
|
Acnamino | Minocycline hydrochloride | Infections | No data available |
|
Acnecide Face 5% gel
1306010C0BUADAB
|
Acnecide | Benzoyl peroxide | Skin | No data available |
|
Acnisal 2% solution
1306010Q0BBAAAA
|
Acnisal | Salicylic acid | Skin | No data available |
|
Acnocin 2000microgram/35microgram tablets
1306020C0BCAAAA
|
Acnocin | Co-cyprindiol (Cyprote acetate/ethinylestradiol) | Skin | No data available |
|
ACo Q10 200mg capsules
091102000BBIPBI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
ACo Q10 30mg capsules
091102000BBIQAI
|
Proprietary compound preparation BNF 0911020 | Other enzyme preparations 0911020 | Nutrition and Blood | No data available |
|
Acoflam 100mg Retard tablets
1001010C0CDADAF
|
Acoflam | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Acoflam 25mg gastro-resistant tablets
1001010C0CDAAAD
|
Acoflam | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Acoflam 50mg gastro-resistant tablets
1001010C0CDABAE
|
Acoflam | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Acoflam 75mg SR tablets
1001010C0CDACAL
|
Acoflam | Diclofenac sodium | Musculoskeletal and Joint Diseases | No data available |
|
Acomplia 20mg tablets
0405020T0BBAAAA
|
Acomplia | Rimonabant | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.